Seven Corners Publishes Open Letter to Shareholders of Merrimack Pharmaceuticals Regarding Annual Meeting

April 24, 2020

Today Seven Corners Capital published an Open Letter to Shareholders of Merrimack Pharmaceuticals (ticker MACK) Regarding Proposals 4 & 5 Contained in MACK's Definitive Proxy Statement for its 2020 Annual Meeting (scheduled for May 28, 2020). THE LETTER ADVOCATES THAT MACK SHAREHOLDERS VOTE AGAINST PROPOSAL #4 AND FOR PROPOSAL #5 (I.E., IN EACH CASE AGAINST OUR BOARD’S RECOMMENDATIONS). For see a detailed discussion of each of these proposals, please see the PDF of our full letter, which has been posted in the Research Section of our website (see here).

Please reload

Featured Posts

SCC Q1 2020 Portfolio Update

May 31, 2020

Please reload

Recent Posts
Please reload

Please reload

50 Vanderbilt Ave, 4th Fl, New York, New York 10017

Content © 2016 Seven Corners Capital Management, LLC. All rights reserved.

  • LinkedIn Social Icon
  • RSS Social Icon
  • Twitter Social Icon
  • SA
  • Image by sporlab